We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

15 hedge funds and large institutions have $17.4M invested in Aldeyra Therapeutics in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding

Funds holding: 5 → 15 (+10)

177% more capital invested

Capital invested by funds: $6.28M → $17.4M (+$11.1M)

Holders
15
Holders Change
+10
Holders Change %
+200%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$3.64M
2
BBA
Baker Bros. Advisors
New York
+$1.45M
3
KCM
Knoll Capital Management
Florida
+$1.39M
4
SFM
Sphera Funds Management
Israel
+$1.17M
5
DCM
DAFNA Capital Management
California
+$357K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$8.66M – – –
PA
2
Perceptive Advisors
New York
$3.63M +$3.64M +357,000 New
BBA
3
Baker Bros. Advisors
New York
$1.45M +$1.45M +142,000 New
KCM
4
Knoll Capital Management
Florida
$1.38M +$1.39M +135,800 New
SFM
5
Sphera Funds Management
Israel
$1.19M +$1.17M +115,000 New
DCM
6
DAFNA Capital Management
California
$356K +$357K +35,000 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$234K – – –
SIM
8
Spark Investment Management
New York
$230K +$117K +11,500 +103%
Morgan Stanley
9
Morgan Stanley
New York
$141K +$128K +12,541 +965%
NIP
10
Nicholas Investment Partners
California
$85K +$85K +8,333 New
Deutsche Bank
11
Deutsche Bank
Germany
$25K +$25.8K +2,530 New
TRCT
12
Tower Research Capital (TRC)
New York
$13K +$12.7K +1,244 New
IF
13
Ironwood Financial
Arizona
$5K +$5.1K +500 New
BIM
14
BlackRock Investment Management
Delaware
$3K – – –
UBS Group
15
UBS Group
Switzerland
$2K +$2.13K +209 New

ALDX Hedge Fund Activity: Q1 2015 in Review

15 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q1 2015, worth a combined $17.4M — up 177% from $6.28M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ALDX positions and 0 closed out — a net gain of 10 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $3.64M.

  • 15 institutional investors held Aldeyra Therapeutics (ALDX) as of Q1 2015, up from 5 in Q4 2014.
  • Funds reported $17.4M of Aldeyra Therapeutics stock for Q1 2015, up 177% quarter-over-quarter.
  • 10 funds opened new Aldeyra Therapeutics positions in Q1 2015 and 0 closed out, a net change of +10 holders.
  • The largest Aldeyra Therapeutics buyer in Q1 2015 was Perceptive Advisors, an estimated $3.64M added.

Based on aggregated 13F filings for Q1 2015.